In vitro diagnostic industry in China.
Song, Haibo, editor.; Dai, Lizhong, 1968- editor.
2023
RB37
Available Online

Linked e-resources

Linked Resource Online Access
Concurrent users Unlimited
Authorized users Authorized users
Document Delivery Supplied Can lend chapters, not whole ebooks

Details

Title In vitro diagnostic industry in China.
Edition Second edition / edited by Haibo Song, Lizhong Dai.
ISBN 9789819931101 (electronic bk.)
981993110X (electronic bk.)
9789819931095
9819931096
DOI https://doi.org/10.1007/978-981-99-3110-1
Published Singapore : Springer, 2023.
Language English
Description 1 online resource (640 pages) : illustrations (black and white, and color).
Item Number 10.1007/978-981-99-3110-1 doi
Call Number RB37
Dewey Decimal Classification 616.0750951
Summary This book systematically describes the achievements and current situation of in vitro diagnostic (IVD) industry in China. It consists of twelve parts, including the overview on the IVD industry in China in 2021, hot technologies and products of IVD industry, academic, technological and product development in the field of IVD, such as biochemical diagnosis, immune-diagnosis, point-of-care testing, molecular diagnosis, blood and body fluid diagnosis, laboratory assembly line, etc. In this second edition, the new contents added include the development of new coronavirus molecular diagnostic products, flight mass spectrometry, tandem mass spectrometry, tumor markers, ELISA immune reagents, autoimmune diagnostics, concomitant diagnosis, fecal and intestinal microecology detection, pathological diagnosis, raw materials for in vitro diagnostic reagents, standard substances and quality controls for in vitro diagnostic reagents, etc., making the content of the whole book more novel and rich. This book is compiled by an editorial committee composed of well-known entrepreneurs, experts and professors in IVD industry in China. It is a reference book for practitioners of IVD industry, medical laboratory and medical staffs all over the world.
Access Note Access limited to authorized users.
Source of Description Description based on print version record.
Added Author Song, Haibo, editor.
Dai, Lizhong, 1968- editor.
Available in Other Form In vitro diagnostic industry in China.
Linked Resources Online Access
Record Appears in Online Resources > Ebooks
All Resources
Current Status and Progress
Opportunities and Challenges
Chemiluminescence Instruments and Reagents
Fully automated enzyme immunological instruments and related instruments
Autoimmune Diagnostics
Tumor Markers
ELISA Immunological Reagents
Biochemical Analytical Instruments and Reagents
Electrolyte Analysis Techniques
Blood Gas Analysis Techniques
Biochemical Assembly Lines
Molecular Diagnosis of Novel Coronavirus
Molecular Diagnostic Analyzers and Reagents
Overview
Domestic and Foreign Real-time Detection Market Situation
Major Domestic Manufacturers
Hemagglutination instruments and reagents
Blood Group Detection Instruments and Supporting Reagents
Urine
Stool and Intestinal Microecology Testing
Semen
Vaginal Discharge
Blood Cell Analyzers and Reagents
Microbial Culture Analyzers and Reagents
Concomitant Diagnosis
Flight Mass Spectrometry Techniques
Tandem Mass Spectrometry
Overview of Pathological Diagnosis
Routine Pathology
Cytopathology
Immunohistochemistry
Molecular Pathology
Numeral Pathology
Classification and Status of Raw Materials for In Vitro Diagnostics
Bottlenecks and Favorable Factors for the Development of Raw Materials for In Vitro Diagnostic Reagents
Development and Application status of National Reference Materials for In Vitro Diagnostic Reagents
Research and Development, Production, and Application status of quality controls for in vitro diagnostic reagents
2021 Results of Listed Companies
Investment and Financing Mergers and Acquisitions of Listed Companies in 2021. .

Browse Subjects

Show more subjects...

Statistics

from
to
Export